Objectives: To assess serum prolidase enzyme activity and oxidative stress in patients with Behçet's disease (BD).
Methods: The study population consisted of BD patients (n = 42) and healthy participants (n = 29). BD patients were classified as active (n = 18) or inactive (n = 24) according to disease activity. Serum prolidase enzyme activity, total antioxidant status (TAS), total oxidative status (TOS), oxidative stress index (OSI), and malondialdehyde (MDA) levels were measured.
Results: In BD patients with active disease, serum prolidase activity was significantly higher compared with the inactive and control participants. Serum prolidase activity was also significantly higher in all BD patients in comparison with controls. Serum prolidase activity was also positively correlated with OSI, C-reactive protein, and active BD. MDA, TOS, and OSI levels were all significantly higher in the BD group when compared with the healthy control participants. Serum TAS levels were significantly lower in BD patients in comparison with healthy controls.
Conclusion: High prolidase activity may indicate critical biological activities relevant to pathological events in BD, and this activity may be a biological indicator of disease. Further studies are needed to verify these findings.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837555 | PMC |
| http://dx.doi.org/10.1179/1351000213Y.0000000072 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prolidase activity in women with polycystic ovarian syndrome undergoing assisted conception.
J Obstet Gynaecol
December 2024
Department of Obstetrics and Gynecology, Health Sciences University, Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.
Prolidase is a manganese (Mn)-dependent cytosolic exopeptidase that degrades imidodipeptides with C-terminal proline or hydroxyproline. Prolidase recycling from imidodipeptides plays a critical role in collagen resynthesis and extracellular matrix (ECM) remodelling. Following an increase in gonadotropins, ovarian and follicular collagen undergo substantial degradation.
View Article and Find Full Text PDFEvaluation of antioxidant enzyme levels, oxidative stress markers and serum prolidase activity in testicular cancer.
Urologia
November 2024
Department of Chemistry, Yuzuncu Yil University, Van, Turkey.
Article Synopsis
- Testicular cancer is a serious disease impacting males, and examining biochemical changes such as serum prolidase activity can help improve treatment approaches.
- A study involving 33 testicular cancer patients and 35 control subjects found increased levels of prolidase and malondialdehyde (a marker of oxidative stress) in cancer patients, while antioxidant enzyme levels were significantly lower.
- The results highlight the link between oxidative stress and testicular cancer, suggesting a need for further research on the potential benefits of antioxidants in treatment strategies.
Prolidase could be considered a sign of inflammation associated with cigarette smoking.
Front Med (Lausanne)
April 2024
Department of Medical Biochemistry, Faculty of Medicine, Baskent University, Konya, Türkiye.
Objectives: Smoking causes inflammation, thickening, and narrowing of the airways. This inflammatory process is a reaction to free radicals and oxidants. Smoking affects collagen metabolism and tissue remodeling.
View Article and Find Full Text PDFSerum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with prostate cancer.
Urol Oncol
April 2024
Department of Urology, Private Yuzyil Gebze Hospital, Kocaeli, Turkey. Electronic address:
Objectives: We aimed to identify serum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with prostate cancers and to evaluate their relationships with each other.
Materials And Methods: A total of 34 male patients with prostate cancer and with a mean age of 64.2 ± 4.
Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in .
RMD Open
December 2023
Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
Prolidase deficiency (PD) is a rare autosomal recessive inborn error of immunity caused by biallelic homozygous or compound heterozygous loss-of-function mutations in , the gene that encodes prolidase. PD typically manifests with variable dysmorphic features, chronic cutaneous ulcers, recurrent infections and autoimmune features, including systemic lupus erythematosus. So far, there is no consensus regarding treatment of PD and its autoimmune manifestations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!